Merck blood clot drug in limbo after mixed results

.

Merck blood clot drug in limbo after mixed results

On Saturday, drug-maker Merck & Co provided details about the last month-announced results of the tests of its experimental blood thinner `vorapaxar', revealing that despite the impressive effectiveness of the blood clot drug in bringing about a significant reduction in cardio vascular incidents in heart patients, worrisome bleeding was also witnessed in people who had suffered a stroke.

According to Merck, while the experimental drug, when combined with standard care, proved effective in bringing down the instances of cardio vascular events in heart patients, it also led to increased bleeding in some patients.

When Merck presented limited data from the study in February this year, the company had said that vorapaxar was proving to be an advantageous drug for heart patients. However, the drug-maker has now revealed that patients who had been administered vorapaxar were also experiencing excessive bleeding.

The Merck revelation, based on the results of the biggest heart-drug studies conducted thus far, implies that the vorapaxar blood clot preventer has shown mixed results; and has thus led to concerns whether the drug-maker will go ahead and seek regulatory approval for the drug.

Noting that the vorapaxar trial shows that there is "clearly a tradeoff here between the protective benefit and the risk of bleeding," Dr. David Morrow - who is a cardiologist from Brigham & Women's Hospital in Boston, and the leader of the trial - said: "Should the drug be approved, he said the challenge for doctors would be to withhold it from patients at likely higher bleeding risk."


Latest News

Police begins probe after alligators found eating dead body in Broward County
Republican Party faces challenge as many plan to avoid convention
Fathom Cruise Brand’s Adonia Continues its Journey to Cuba after “Electrical Dif
Oil Prices Rise in the U.S Right at the Beginning of the Summer Driving Season w
With Increase in Exports the Australian Dollar Gains the Most in Four Weeks
Viacom Board of Directors Stick Together to Fight Redstone Family’s Effort to Ej
Worshipers lose church after decades of fight
Criticism after rare gorilla is killed to save child in Cincinnati Zoo
Noble Group Announced Its Chief Executive Yusuf Alireza is Resigning due to “Fam
Puerto Rico Gets Some Relief with Rescue Bill and Demand and Improving Agricultu
PageProof Learnt from the U.S Market, Language is Important!
James Bullard St. Louis Federal Reserve President says Global Markets Appear to